/

Empresas

No

No verificado

Novaliq

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMultimediaSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa

08/07/2025

Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD

Fuente

Editor

1.00

0

02/10/2024

Multimedia

Mercado laboral

Industria

Biotecnología

Salud

Farmacéutica

Óptica

Medicina - Varios

Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye® (Ciclosporin 0.1% Eye Drops Solution)

Fuente

Editor

1.00

0

29/07/2024

Novaliq Receives Positive CHMP Opinion for Vevizye® in Dry Eye Disease

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0